[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@HumleRun Avatar @HumleRun HumleRun

HumleRun posts on X about $dawn, dawn, $hnsa, $skye the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence cryptocurrencies stocks finance

Social topic influence $dawn #16, dawn #1543, $hnsa #1, $skye #3, $sanion #1, $atorx #1, $crbp #3, $aciu #1, $guard, $catx

Top assets mentioned Dawn Protocol (DAWN) Acadia Pharmaceuticals Inc. (ACAD) Eli Lilly and Company (LLY) Smart Layer Network (SLN)

Top Social Posts #

Top posts by engagements in the last XX hours

"$DAWN -XX% since last week. $SKYE 's failed top line results and more then XX% down on the day resulted in a total week lost of the portfolio -39%"
X Link @HumleRun 2025-10-11T06:04Z XX followers, XXX engagements

"Portfolio update Increased my position in $Sanion in the dip (down to11) at the cost of $ATORX $GUARD $HNSA (temporary). Saniona +48% on the week. $CATX is in a good momentum now and +36% since Monday. $CRBP +48% the last week. $ACIU -XX% the last week"
X Link @HumleRun 2025-10-11T06:04Z XX followers, XXX engagements

"Potential future partners could include major pharma like Novo Nordisk Eli Lilly Pfizer or Amgen with robust GLP-1 and metabolic pipelines. Specialized firms like Rhythm Pharmaceuticals or Acadia Pharmaceuticals focused on hyperphagia are plausible candidates"
X Link @HumleRun 2025-10-11T11:36Z XX followers, XXX engagements

"The pipeline includes KLTO-202 for ALS and KLTO-101 for Alzheimer's and Parkinson's. Key milestones include initiating manufacturing for KLTO-202 in June 2025 forming a partnership with AAVnerGene Inc. in July 2025 to enhance gene therapy production"
X Link @HumleRun 2025-10-14T17:21Z XX followers, XX engagements

"$HNSA US Phase X ConfIdeS trial for imlifidase showed superior 12-month kidney function (eGFR p0.0001) in highly sensitized transplant patients. With XX% retention Hansa plans a BLA submission for FDA accelerated approval by end of 2025. Bought in at 38sek today"
X Link @HumleRun 2025-09-25T17:03Z XX followers, XXX engagements

"Sanionas Phase 2b trials are paused due to funding constraints not safety or efficacy concerns. Saniona holds global rights to Tesomet and is exploring opportunities to advance its development"
X Link @HumleRun 2025-10-11T11:36Z XX followers, XX engagements

"Been a rough week for $DAWN so far. Added some more yesterday and now it counts for XXX% of the portfolio. $SLN had to give way temporarily but I think this opportunity was to good to miss out on. $SLN q1 report on tuesday so probably wait it out still positive thou"
X Link @HumleRun 2025-05-08T05:12Z XX followers, XXX engagements

"In September 2025 Klotho signed a letter of intent to acquire assets from Turn Biotechnologies for anti-aging advancements but this expired in October 2025 as the board refocused on core Klotho-based therapies"
X Link @HumleRun 2025-10-14T17:21Z XX followers, XX engagements

"My biggest position $Sanion is more and more focusing on neurological diseases (schizofrenaalzheimers epilepsy and depression). $ATORX mainly in oncology and $HNSA in auto immune diseases and kidney transplant"
X Link @HumleRun 2025-09-27T11:28Z XX followers, XXX engagements

"Looks like this will be one of the greatest days over the board for my Us listed stocks. All have surged over the day (night here) and a pleasant ending to the week. First I thought there was some leak in AC Immune but now the rest following too. $Skye $Dawn $Crbp $ACIU"
X Link @HumleRun 2025-10-03T19:22Z XX followers, XXX engagements